XOMAPSMALL

XOMA Corporation

HealthcareBiotechnology
$25.49
$0.00(+0.12%)
52W$25.14
$30.00
Updated Jun 28, 02:00 AM
RSI49
RS Rating42/99
Beta0.02
Volatility13%
F-Score5/9
Mkt Cap$307M
DOWNTREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

DOWNTREND

XOMA Corporation is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 42), showing significant lag compared to the market leaders. Earnings growth of 183% provides fundamental context to the price action. A decisive close above the 200-day moving average is required to signal a potential trend reversal.

Relative Strength
42
out of 99
Lagging
Trend Score
0/4
Minervini Criteria
DOWNTREND
Risk (Beta)
0.02
vs S&P 500
LOW VOL
52W Position
7%
from 52W low
Near Low
Trend & Momentum Analysis

Trend Template (Minervini)

DOWNTREND0/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$25.50
50 SMA > 100 SMA$25.76
100 SMA > 150 SMA$26.02
150 SMA > 200 SMA$26.12

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$25.47+0.09%ABOVE
50 SMA$25.50-0.05%BELOW
100 SMA$25.76-1.04%BELOW
150 SMA$26.02-2.04%BELOW
200 SMA$26.12-2.41%BELOW

Price Performance

1D+0.1%
1W+0.0%
1M+0.5%
3M-0.4%
6M-4.7%
YTD-6.0%
1Y-0.7%
3Y+1.9%
52-Week Trading Range7% from low
$25.49
52W Low$25.14
52W High$30.00

Technical Indicators

RSI (14)NEUTRAL
49.0
305070
Setup ScoreCOOL
4/10
Base depth: 8.5%

Risk Profile

Beta
0.02
52W Vol
13%
ATR
$0.06
Max DD (1Y)
-7%

Volume Analysis

Today
4.7K
50D Avg
3.0K
Vol Ratio
1.56x
Liquidity
ILLIQUID

Earnings Momentum

Q2'25-48%
$0.52
Q3'25+144%
$0.70
Q4'25-68%
$0.26
Q1'26+183%
$0.17
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:-0.61%
5 Years:+12.16%
3 Years:+105.30%
TTM:-36.12%

Compounded Profit Growth

10 Years:
5 Years:+13.36%
3 Years:
TTM:+468.97%

Stock Price CAGR

10 Years:+0.43%
5 Years:-0.43%
3 Years:+1.87%
1 Year:-0.66%

Return on Equity

10Y Avg:15.4%
5Y Avg:-3.9%
3Y Avg:-6.8%
Last Year:32.4%

Key Metrics

Market Cap$307M
Gross Margin94.3%
Net Margin60.8%
Piotroski F-Score5/9

Frequently Asked Questions

Is XOMAP in an uptrend right now?

XOMAP has a trend score of 0/4 based on Minervini's Stage Analysis. Currently showing broken structure - 0 of 4 trend criteria are met.

Is XOMAP overbought or oversold?

XOMAP's RSI (14) is 49. The stock is in neutral territory, neither overbought nor oversold.

Is XOMAP outperforming the market?

XOMAP has a Relative Strength (RS) Rating of 42 out of 99. XOMAP is currently lagging the broader market.

Where is XOMAP in its 52-week range?

XOMAP is trading at $25.49, which is 85% of its 52-week high ($30.00) and 7% above its 52-week low ($25.14).

How volatile is XOMAP?

XOMAP has a Beta of 0.02 and 52-week volatility of 13%. It's less volatile than the S&P 500 - generally more stable.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.